Our publications

Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model

Veličković VM, Borisenko O, Svensson M, Spelman T, Siebert U. Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model. PLoS One. 2018 Sep 27;13(9):e0204643.

An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany

O Borisenko, J Müller-Ehmsen, JA Lindenfeld, E Rafflenbeul, C Hamm. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany. BMC Cardiovascular Disorders, 2018. 18:163.

Cost–utility analysis of bariatric surgery

Borisenko O,  Lukyanov V,  Ahmed A.R. Cost-utility analysis of bariatric surgery. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10857.

Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium

Borisenko O, Lukyanov V, Debergh I, Dillemans B. Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium. J Med Econ. 2018 Jan 10:1-9.

Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis

Sanchez-Santos R, Padin EM, Adam D, Borisenko O, Fernandez SE, Dacosta EC, Fernández SG, Vazquez JT, de Adana JCR, de la Cruz Vigo F. Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res. 2017 Nov 30:1-10.

Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study

Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenterrandomized controlled study. J Hepatol. 2017 Nov;67(5):940-949.

Patient Characteristics, Procedural and Safety Outcomes of Bariatric Surgery in England: a Retrospective Cohort Study-2006-2012

Sun S, Borisenko O, Spelman T, Ahmed AR. Patient Characteristics, Procedural and Safety Outcomes of Bariatric Surgery in England: a Retrospective Cohort Study-2006-2012. Obes Surg. 2017 Oct 26. doi: 10.1007/s11695-017-2978-x.

Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling

Borisenko O, Mann O, Duprée A. Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling. BMC Surg. 2017 Aug 3;17(1):87.

Cost analysis of bariatric surgery in Denmark made with a decision-analytic model

O Borisenko, V Lukyanov, SP Johnsen,  P Funch-Jensen. Cost analysis of bariatric surgery in Denmark made with a decision-analytic model. Dan Med J 2017;64(8):A5401

Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling

Lucchese M, Borisenko O, Mantovani LG, Cortesi PA, Cesana G, Adam D, Burdukova E, Lukyanov V, Di Lorenzo N. Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling. Obes Facts. 2017 Jun 10;10(3):261-272. 

Systematic review of risk prediction models for diabetes after bariatric surgery

Zhang R, Borisenko O, Telegina I, Hargreaves J, Ahmed AR, Sanchez Santos R, Pring C, Funch-Jensen P, Dillemans B, Hedenbro JL. Systematic review of risk prediction models for diabetes after bariatric surgery. Br J Surg, 2016 Oct;103(11);1420-7.

Systematic literature review of use of blood glucose monitoring in phase III clinical studies of insulin analogs

Miikkulainen K, Caruso A, Mast O, Zhang R, Borisenko O. Systematic literature review of use of blood glucose monitoring in phase III clinical studies of insulin analogs. BMC Endocr Disord. 2016 May 4;16(1):21.